Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
Ac-225 ErbB3 targeted radiotherapy
i
Other names:
Ac-225 ErbB3 targeted radiotherapy, Actinium-225 ErbB3 targeting radiotherapy, Ac-225-HER3-ARC, 225Ac-HER3-ARC, Actinium-225 (Ac-225)-conjugated anti-HER3 antibody
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(4)
News
Trials
Company:
Actinium, LG Chem
Drug class:
HER3 inhibitor, Alpha radiation emitter
Related drugs:
‹
MCLA-128 (16)
MM-121 (12)
ISU104 (4)
AV-203 (1)
LJM-716 (1)
SI-B001 (1)
U3-1287 (1)
177Lu-HER3 ARC (0)
CDX-3379 (0)
GSK2849330 (0)
MM 111 (0)
Sym013 (0)
INCB7839 (0)
MEHD7945A (0)
MM-141 (0)
RG7116 (0)
AZD8931 (0)
lintuzumab-Ac225 (4)
RYZ101 (2)
radium Ra-223 dichloride (2)
ORM-2110 (1)
BAY2701439 (1)
I-131-apamistamab (1)
Undisclosed EGFRvIII-targeted alpha therapy (1)
211At-OKT10-B10 (0)
212Pb-DOTAM-GRPR1 (0)
AAA817 (0)
AB001 (0)
CONV01-α (0)
FPI-1434 (0)
FPI-1966 (0)
FPI-2265 (0)
Iomab-ACT (0)
JNJ-6420 (0)
VMT-01 (0)
VMT-𝛼-NET (0)
[²¹¹At]PTT (0)
BAY 2315497 (0)
BAY 2287411 (0)
MCLA-128 (16)
MM-121 (12)
ISU104 (4)
AV-203 (1)
LJM-716 (1)
SI-B001 (1)
U3-1287 (1)
177Lu-HER3 ARC (0)
CDX-3379 (0)
GSK2849330 (0)
MM 111 (0)
Sym013 (0)
INCB7839 (0)
MEHD7945A (0)
MM-141 (0)
RG7116 (0)
AZD8931 (0)
lintuzumab-Ac225 (4)
RYZ101 (2)
radium Ra-223 dichloride (2)
ORM-2110 (1)
BAY2701439 (1)
I-131-apamistamab (1)
Undisclosed EGFRvIII-targeted alpha therapy (1)
211At-OKT10-B10 (0)
212Pb-DOTAM-GRPR1 (0)
AAA817 (0)
AB001 (0)
CONV01-α (0)
FPI-1434 (0)
FPI-1966 (0)
FPI-2265 (0)
Iomab-ACT (0)
JNJ-6420 (0)
VMT-01 (0)
VMT-𝛼-NET (0)
[²¹¹At]PTT (0)
BAY 2315497 (0)
BAY 2287411 (0)
›
Associations
(4)
News
Trials
VERI cancer hierarchy
Reset Filters
ERBB3 expression
Renal Cell Carcinoma
ERBB3 expression
Renal Cell Carcinoma
Ac-225 ErbB3 targeted radiotherapy
Sensitive: D – Preclinical
Ac-225 ErbB3 targeted radiotherapy
Sensitive
:
D
Ac-225 ErbB3 targeted radiotherapy
Sensitive: D – Preclinical
Ac-225 ErbB3 targeted radiotherapy
Sensitive
:
D
ERBB3 expression
Prostate Cancer
ERBB3 expression
Prostate Cancer
Ac-225 ErbB3 targeted radiotherapy
Sensitive: D – Preclinical
Ac-225 ErbB3 targeted radiotherapy
Sensitive
:
D
Ac-225 ErbB3 targeted radiotherapy
Sensitive: D – Preclinical
Ac-225 ErbB3 targeted radiotherapy
Sensitive
:
D
ERBB3 expression
Colorectal Cancer
ERBB3 expression
Colorectal Cancer
Ac-225 ErbB3 targeted radiotherapy
Sensitive: D – Preclinical
Ac-225 ErbB3 targeted radiotherapy
Sensitive
:
D
Ac-225 ErbB3 targeted radiotherapy
Sensitive: D – Preclinical
Ac-225 ErbB3 targeted radiotherapy
Sensitive
:
D
ERBB3 expression
Ovarian Cancer
ERBB3 expression
Ovarian Cancer
Ac-225 ErbB3 targeted radiotherapy
Sensitive: D – Preclinical
Ac-225 ErbB3 targeted radiotherapy
Sensitive
:
D
Ac-225 ErbB3 targeted radiotherapy
Sensitive: D – Preclinical
Ac-225 ErbB3 targeted radiotherapy
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login